• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Lazard LTD. Lazard LTD. (Amendment)

    2/14/22 2:34:37 PM ET
    $LAZ
    Investment Managers
    Finance
    Get the next $LAZ alert in real time by email
    SC 13G/A 1 laz13gadec21.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2) Lazard Ltd (Name of Issuer) COMMON STOCK (Title of Class of Securities) G54050102 (CUSIP NUMBER) December 31, 2021 (Date of Event which Requires Filing of Statement) Check the appropriate box to designate the Rule pursuant to which this Schedule is filed: [x] Rule 13d - 1(b) Rule 13d - 1(c) Rule 13d - 1(d) 1. Name of Reporting Person T. ROWE PRICE ASSOCIATES, INC. 52-0556948 2. Check the Appropriate Box if a Member of a Group NOT APPLICABLE 3. SEC Use Only 4. Citizenship or Place of Organization Maryland Number of Shares Beneficially Owned by Each Reporting Person With 5. Sole Voting Power* 1,377,195 6. Shared Voting Power* 0 7. Sole Dispositive Power* 3,378,916 8. Shared Dispositive Power 0 9. Aggregate Amount Beneficially Owned by Each Reporting Person 3,378,916 10. Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares NOT APPLICABLE 11. Percent of Class Represented by Amount in Row 9 2.9% 12. Type of Reporting Person IA *Any shares reported in Items 5 and 6 are also reported in Item 7. Item 1(a) Name of Issuer: Lazard Ltd Item 1(b) Address of Issuer's Principal Executive Offices: CLARENDON HOUSE, 2 CHURCH STREET, HAMILTON, BERMUDA HM II Item 2(a) Name of Person(s) Filing: (1) T. ROWE PRICE ASSOCIATES, INC. ("Price Associates") Item 2(b) Address of Principal Business Office: 100 E. Pratt Street, Baltimore, MD 21202 Item 2(c) Citizenship or Place of Organization: (1) Maryland Item 2(d) Title of Class of Securities: COMMON STOCK Item 2(e) Cusip Number: G54050102 Item 3: The person filing this Schedule 13G is an: X Investment Adviser registered under Section 203 of the Investment Advisers Act of 1940 Item 4: Reference is made to Items 5-11 on the preceding pages of this Schedule 13G. Item 5: Ownership of Five Percent or Less of a Class This statement is being filed to report the fact that, as of the date of this report, the reporting person(s) has (have) ceased to be the beneficial owner of more than five percent of the class of securities. Item 6: Ownership of More than Five Percent on Behalf of Another Person (1) Price Associates does not serve as custodian of the assets of any of its clients; accordingly, in each instance only the client or the client's custodian or trustee bank has the right to receive dividends paid with respect to, and proceeds from the sale of, such securities. The ultimate power to direct the receipt of dividends paid with respect to, and the proceeds from the sale of, such securities, is vested in the individual and institutional clients which Price Associates serves as investment adviser. Any and all discretionary authority which has been delegated to Price Associates may be revoked in whole or in part at any time. Except as may be indicated if this is a joint filing with one of the registered investment companies sponsored by Price Associates which it also serves as investment adviser ("T. Rowe Price Funds"), not more than 5% of the class of such securities is owned by any one client subject to the investment advice of Price Associates. (2) With respect to securities owned by any one of the T. Rowe Price Funds, only the custodian for each of such Funds, has the right to receive dividends paid with respect to, and proceeds from the sale of, such securities. No other person is known to have such right, except that the shareholders of each such Fund participate proportionately in any dividends and distributions so paid. Item 7: Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company. Not Applicable Item 8: Identification and Classification of Members of the Group Not Applicable Item 9: Notice of Dissolution of Group Not Applicable Item 10: Certification By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. T. Rowe Price Associates, Inc. hereby declares and affirms that the filing of Schedule 13G shall not be construed as an admission that Price Associates is the beneficial owner of the securities referred to, which beneficial ownership is expressly denied. Signature. After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. T. ROWE PRICE ASSOCIATES, INC. Date: February 14, 2022 Signature: /s/ David Oestreicher Name & Title: David Oestreicher, Executive Vice President 12/31/2021
    Get the next $LAZ alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $LAZ

    DatePrice TargetRatingAnalyst
    1/26/2026$65.00Buy
    BofA Securities
    12/11/2025$54.00Neutral
    UBS
    10/3/2025$56.00Market Perform
    BMO Capital Markets
    8/25/2025$65.00Mkt Perform → Outperform
    Keefe Bruyette
    4/7/2025$56.00 → $33.00Equal-Weight → Underweight
    Morgan Stanley
    1/3/2025Outperform → Peer Perform
    Wolfe Research
    12/20/2024$65.00 → $57.00Outperform → Mkt Perform
    Keefe Bruyette
    12/9/2024$60.00 → $63.00Overweight → Equal-Weight
    Morgan Stanley
    More analyst ratings

    $LAZ
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Lazard Reports February 2026 Assets Under Management

    NEW YORK, March 10, 2026 /PRNewswire/ -- Lazard, Inc. (NYSE:LAZ) reported today that its preliminary assets under management ("AUM") as of February 28, 2026 totaled approximately $277.7 billion. The month's AUM included market appreciation of $8.9 billion, net inflows of $4.2 billion, FX depreciation of $0.8 billion and a decrease of $1.5 billion related to the sale of our stake in the Edgewater Funds management vehicles. LAZARD, INC.ASSETS UNDER MANAGEMENT ("AUM")(unaudited)($ in millions)As of: February 28,  January 31,  20261 2026Equity$207,093$195,775Fixed Income36,46735,758

    3/10/26 6:45:00 AM ET
    $LAZ
    Investment Managers
    Finance

    Lazard Global Total Return and Income Fund Declares Monthly Distribution and Issues Estimated Sources of the Distribution Announced in January

    NEW YORK, Feb. 23, 2026 /PRNewswire/ -- Lazard Global Total Return and Income Fund, Inc. (the "Fund") (NYSE:LGI) is confirming today, pursuant to its Managed Distribution Policy, as previously authorized by its Board of Directors, a monthly distribution of $0.15340 per share on the Fund's outstanding common stock. The distribution is payable on March 23, 2026, to shareholders of record on March 10, 2026. The ex-dividend date is March 10, 2026. The Fund will pay a previously declared distribution today, February 23, 2026. The following table sets forth the estimated amounts of th

    2/23/26 5:07:00 PM ET
    $LAZ
    $LGI
    Investment Managers
    Finance

    LAZARD EXPANDS ITS HEALTHCARE SERVICES TEAM WITH ADDITION OF JOHN KOSKI AND ROBERT LOWE

    NEW YORK, Feb. 18, 2026 /PRNewswire/ -- Lazard, Inc. (NYSE:LAZ) today announced that John Koski and Rob Lowe joined the firm in New York as Managing Directors in the Healthcare Group, advising on transactions across the healthcare services sector. These appointments underscore Lazard's continued investment in its Healthcare Group and focus on providing thoughtful, high-quality strategic advice to executives, boards, and investors across the healthcare sector. This announcement also reflects the ongoing momentum behind Lazard's long-term growth strategy, as exceptional bankers are increasingly drawn to the firm's entrepreneurial culture, renowned brand, and global platform. 

    2/18/26 7:30:00 AM ET
    $LAZ
    Investment Managers
    Finance

    $LAZ
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    BofA Securities initiated coverage on Lazard with a new price target

    BofA Securities initiated coverage of Lazard with a rating of Buy and set a new price target of $65.00

    1/26/26 10:01:23 AM ET
    $LAZ
    Investment Managers
    Finance

    UBS resumed coverage on Lazard with a new price target

    UBS resumed coverage of Lazard with a rating of Neutral and set a new price target of $54.00

    12/11/25 9:10:59 AM ET
    $LAZ
    Investment Managers
    Finance

    BMO Capital Markets initiated coverage on Lazard with a new price target

    BMO Capital Markets initiated coverage of Lazard with a rating of Market Perform and set a new price target of $56.00

    10/3/25 8:41:45 AM ET
    $LAZ
    Investment Managers
    Finance

    $LAZ
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Lazard Inc.

    SCHEDULE 13G/A - Lazard, Inc. (0001311370) (Subject)

    3/6/26 10:05:20 AM ET
    $LAZ
    Investment Managers
    Finance

    SEC Form 10-K filed by Lazard Inc.

    10-K - Lazard, Inc. (0001311370) (Filer)

    2/23/26 4:33:41 PM ET
    $LAZ
    Investment Managers
    Finance

    Lazard Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

    8-K - Lazard, Inc. (0001311370) (Filer)

    2/2/26 5:00:04 PM ET
    $LAZ
    Investment Managers
    Finance

    $LAZ
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Hogbin Christopher

    4 - Lazard, Inc. (0001311370) (Issuer)

    3/19/26 7:37:35 PM ET
    $LAZ
    Investment Managers
    Finance

    SEC Form 4 filed by Farr Tracy

    4 - Lazard, Inc. (0001311370) (Issuer)

    3/18/26 5:58:41 PM ET
    $LAZ
    Investment Managers
    Finance

    SEC Form 4 filed by Orszag Peter Richard

    4 - Lazard, Inc. (0001311370) (Issuer)

    3/18/26 5:58:35 PM ET
    $LAZ
    Investment Managers
    Finance

    $LAZ
    Financials

    Live finance-specific insights

    View All

    Lazard Global Total Return and Income Fund Declares Monthly Distribution and Issues Estimated Sources of the Distribution Announced in January

    NEW YORK, Feb. 23, 2026 /PRNewswire/ -- Lazard Global Total Return and Income Fund, Inc. (the "Fund") (NYSE:LGI) is confirming today, pursuant to its Managed Distribution Policy, as previously authorized by its Board of Directors, a monthly distribution of $0.15340 per share on the Fund's outstanding common stock. The distribution is payable on March 23, 2026, to shareholders of record on March 10, 2026. The ex-dividend date is March 10, 2026. The Fund will pay a previously declared distribution today, February 23, 2026. The following table sets forth the estimated amounts of th

    2/23/26 5:07:00 PM ET
    $LAZ
    $LGI
    Investment Managers
    Finance

    Lazard Reports Fourth Quarter and Full Year 2025 Results

    Record full-year Financial Advisory adjusted net revenue of $1.8 billionRecord full-year Asset Management inflows and total AUM up 12% year-over-yearFinancial Advisory ahead of 2030 targets, with revenue per MD of $8.9 million1 and 21 Managing Directors hired during 2025NEW YORK, Jan. 29, 2026 /PRNewswire/ -- Lazard, Inc. (NYSE:LAZ) today reported net revenue of $907 million and adjusted net revenue2 of $892 million for the quarter ended December 31, 2025. For the full year of 2025, Lazard reported net revenue of $3,099 million and adjusted net revenue2 of $3,030 million. On a

    1/29/26 6:30:00 AM ET
    $LAZ
    Investment Managers
    Finance

    Lazard Declares Quarterly Dividend of $0.50 per Share

    NEW YORK, Jan. 28, 2026 /PRNewswire/ -- Lazard, Inc. (NYSE:LAZ) today announced that its Board of Directors has voted to declare a quarterly dividend of $0.50 per share on its outstanding common stock. The dividend is payable on February 20, 2026, to stockholders of record on February 9, 2026. About Lazard Founded in 1848, Lazard is the preeminent financial advisory and asset management firm, with operations in North and South America, Europe, the Middle East, Asia, and Australia. Lazard provides advice on mergers and acquisitions, capital markets and capital solutions, restr

    1/28/26 4:15:00 PM ET
    $LAZ
    Investment Managers
    Finance

    $LAZ
    Leadership Updates

    Live Leadership Updates

    View All

    LAZARD EXPANDS ITS HEALTHCARE SERVICES TEAM WITH ADDITION OF JOHN KOSKI AND ROBERT LOWE

    NEW YORK, Feb. 18, 2026 /PRNewswire/ -- Lazard, Inc. (NYSE:LAZ) today announced that John Koski and Rob Lowe joined the firm in New York as Managing Directors in the Healthcare Group, advising on transactions across the healthcare services sector. These appointments underscore Lazard's continued investment in its Healthcare Group and focus on providing thoughtful, high-quality strategic advice to executives, boards, and investors across the healthcare sector. This announcement also reflects the ongoing momentum behind Lazard's long-term growth strategy, as exceptional bankers are increasingly drawn to the firm's entrepreneurial culture, renowned brand, and global platform. 

    2/18/26 7:30:00 AM ET
    $LAZ
    Investment Managers
    Finance

    Lazard Asset Management Appoints Eric Van Nostrand as Chief Investment Officer

    CIO role established to reinforce investment excellence, deepen global investment connectivity and further enhance Lazard's research-driven platform Lazard Asset Management ("LAM") today announced that Eric Van Nostrand has been appointed Chief Investment Officer (CIO), a newly created role established to strengthen the cohesion, discipline, and effectiveness of LAM's global investment platform. As CIO, he will be responsible for investment oversight and for advancing the processes that support consistent, long‑term outcomes for clients. In this role, Mr. Van Nostrand will partner closely with LAM's investment leaders to strengthen portfolio construction standards, deepen research rigor

    1/6/26 8:30:00 AM ET
    $LAZ
    Investment Managers
    Finance

    Lazard Bolsters Global Industrials Practice by Adding Three New Managing Directors

    Bill Young Joins the Firm as a Managing Director and Head of Diversified Industrials Jean Greene Rejoins the Firm as a Managing Director Paolo Battaglia to Join the Firm as a Managing Director Lazard, Inc. (NYSE:LAZ), the preeminent global financial advisory and asset management firm, announced today the appointments of Bill Young, Jean Greene, and Paolo Battaglia as Managing Directors in the firm's Global Industrials Group, all based in New York. These appointments further strengthen Lazard's market-leading global Industrials franchise, which advises clients across diversified industrials, building products, chemicals, paper & packaging, transportation & logistics, industrial technology,

    11/25/25 7:45:00 AM ET
    $LAZ
    Investment Managers
    Finance

    $LAZ
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Lazard Inc.

    SC 13G - Lazard, Inc. (0001311370) (Subject)

    11/8/24 2:17:07 PM ET
    $LAZ
    Investment Managers
    Finance

    SEC Form SC 13G/A filed by Lazard LTD. Lazard LTD. (Amendment)

    SC 13G/A - Lazard, Inc. (0001311370) (Subject)

    2/14/24 9:41:26 AM ET
    $LAZ
    Investment Managers
    Finance

    SEC Form SC 13G/A filed by Lazard LTD. Lazard LTD. (Amendment)

    SC 13G/A - Lazard, Inc. (0001311370) (Subject)

    2/9/24 9:16:05 AM ET
    $LAZ
    Investment Managers
    Finance